InvestLog
MLTX logo

MLTX

MoonLake ImmunotherapeuticsNASDAQHealthcare
$17.36+5.08%ClosedMarket Cap: $1.25B

As of 2026-04-06

Insider Statistics (Q1 2026)

Purchases

3

Sales

3

Buy/Sell Ratio

1.00

Total Bought

$0.00

Total Sold

$3.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu Apr 02BVF PARTNERS L P/ILdirector, 10 percent owner: Sell248,530$16.791,039,238
Thu Apr 02BVF PARTNERS L P/ILdirector, 10 percent owner: Sell1,569,116$16.796,599,722
Thu Apr 02BVF PARTNERS L P/ILdirector, 10 percent owner: Sell1,932,354$16.798,302,735
Fri Jan 09Bodenstedt Matthiasofficer: Chief Financial OfficerSell354,296$0.001,276,305
Fri Jan 09Santos da Silva Jorgedirector, officer: Chief Executive OfficerSell520,342$11.29520,342
Fri Jan 09Reich Kristianofficer: Chief Scientific OfficerSell520,342$11.29520,342
Mon Dec 22Reich Kristianofficer: Chief Scientific OfficerSell35,389$0.0035,389
Mon Dec 22Reich Kristianofficer: Chief Scientific OfficerSell35,389$0.000
Mon Dec 22Reich Kristianofficer: Chief Scientific OfficerSell1,052$0.000
Mon Dec 22Santos da Silva Jorgedirector, officer: Chief Executive OfficerSell196,316$0.003,074,893
Mon Dec 22Bodenstedt Matthiasofficer: Chief Financial OfficerSell294,473$0.000
Mon Dec 22Bodenstedt Matthiasofficer: Chief Financial OfficerSell8,754$0.000
Mon Dec 22Bodenstedt Matthiasofficer: Chief Financial OfficerSell294,473$0.00922,009